21 August 2019 - Gilead Sciences took the unusual step of mounting a challenge to U.S. government patents on Wednesday, ...
25 June 2019 - Novartis has won a U.S. federal court order preventing rival generic makers from selling versions of the ...
7 May 2019 - If there was any hope that Congress might overhaul the way this country doles out the ...
11 February 2019 - In a perfect world, the system for conveying medications from their makers to patients should be ...
7 December 2018 - A rare point of consensus following the midterm elections is that Americans are adamant about lowering ...
18 October 2018 - Agreements provide non-exclusive license to Fresenius Kabi for Humira related intellectual property in the U.S. effective 30 ...
13 August 2018 - On May 30, 2018, President Trump signed into law the federal Right to Try Act of 2017,1 ...
8 November 2017 - In May 2017, the US FDA denied a 6-month extension of market exclusivity for Sensipar (cinacalcet), ...